Pdude: thx for the thorough response. I agree that V will likely show to be an effective treatment. I still don’t understand zero interest from the Street in this area though...they have access to all of the same data and no one cares. There were 100 or so people on the Argentina webcast.....probably 90 retail AMRN shareholders, lol.
Also, unpopular opinion, but I’m not impressed at the speed that these studies were established and conducted. Don’t get me wrong, I don’t think Amarin separately would have done them quicker, but getting first results 15 months after the pandemic started isn’t exactly agility in my book. Again, they have one drug. Especially for an illness that lasts only a few weeks. We should have been hearing results last fall.